Drug Type Small molecule drug |
Synonyms 5 methoxypsoralen, Psoraderm |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC12H8O4 |
InChIKeyBGEBZHIAGXMEMV-UHFFFAOYSA-N |
CAS Registry484-20-8 |
Start Date02 Feb 2010 |
Sponsor / Collaborator |
Start Date12 Jul 2007 |
Sponsor / Collaborator- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | 5-Methoxypsoralen |
Indication | Country/Location | Organization | Date |
---|---|---|---|
HIV Infections | - | - | |
Psoriasis | - | - | |
Skin Neoplasms | - | - | |
Vitiligo | - | - |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |